Daiwa Securities Group
MRVI icon

Daiwa Securities Group’s Maravai LifeSciences MRVI Stock Holding History

Daiwa Securities Group’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-490
Closed -$2K – 1342
2025
Q4 		$2K Hold
490
– – ﹤0.01% 1315
2025
Q3 		$1K Hold
490
– – ﹤0.01% 1312
2025
Q2 		$1K Hold
490
– – ﹤0.01% 1269
2025
Q1 		$1K Hold
490
– – ﹤0.01% 1235
2024
Q4 		$3K Hold
490
– – ﹤0.01% 1199
2024
Q3 		$4K Hold
490
– – ﹤0.01% 1187
2024
Q2 		$4K Hold
490
– – ﹤0.01% 1214
2024
Q1 		$4K Hold
490
– – ﹤0.01% 1222
2023
Q4 		$3K Hold
490
– – ﹤0.01% 1248
2023
Q3 		$5K Hold
490
– – ﹤0.01% 1159
2023
Q2 		$6K Hold
490
– – ﹤0.01% 1169
2023
Q1 		$7K Hold
490
– – ﹤0.01% 1134
2022
Q4 		$7K Hold
490
– – ﹤0.01% 1131
2022
Q3 		$13K Hold
490
– – ﹤0.01% 1117
2022
Q2 		$14K Buy
490
+106
+28% +$3.36K ﹤0.01% 1128
2022
Q1 		$14K Hold
384
– – ﹤0.01% 1125
2021
Q4 		$16K Buy
+384
New +$15.6K ﹤0.01% 1130

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Daiwa Securities Group's MRVI Position: Q1 2026 in Review

Daiwa Securities Group sold out of Maravai LifeSciences (MRVI) in Q1 2026, closing a stake of 490 shares — an estimated $2K sold.

Daiwa Securities Group first reported a position in MRVI in Q4 2021 and held it in 17 quarters. The position peaked at $16K in Q4 2021. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Daiwa Securities Group reported no remaining Maravai LifeSciences position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 490 Maravai LifeSciences shares in Q1 2026, an estimated $2K.
  • Daiwa Securities Group first reported a position in Maravai LifeSciences in Q4 2021 and held it in 17 quarters.
  • Daiwa Securities Group's Maravai LifeSciences position peaked at $16K in Q4 2021.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.